Outcomes for Anaplastic Glioma Treated With Radiation Therapy With or Without Concurrent Temozolomide

被引：0
|
作者：
McTyre, E. [1 ]
Lucas, J. T., Jr. [1 ]
Helis, C. [2 ]
Farris, M. [1 ]
Houseknecht, K. [1 ]
Mott, R. [1 ]
Laxton, A. W. [1 ]
Tatter, S. B. [1 ]
Lesser, G. J. [1 ]
Chan, M. D. [1 ]
机构：
[1] Wake Forest Univ, Baptist Med Ctr, Winston Salem, NC 27109 USA
[2] Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2015年 / 93卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2015.07.824
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2276
引用
收藏
页码：E108 / E108
页数：1
相关论文
共 50 条
  • [31] Whole brain radiation therapy (WBRT) with or without concurrent temozolomide for brain metastases in breast cancer patients
    El-Sadda, W. M.
    Abdel-Halim, I. I.
    El-Ibrashi, M. M.
    Magdi, M. M.
    CANCER RESEARCH, 2016, 76
  • [32] Should concomitant and adjuvant treatment with temozolomide be used as standard therapy in patients with anaplastic glioma?
    Siker, Malika L.
    Chakravarti, Arnab
    Mehta, Minesh P.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 60 (02) : 99 - 111
  • [33] Pseudoprogression in pediatric diffuse pontine glioma treated with radiation and concomitant temozolomide
    Lafay-Cousin, Lucie
    Feniak, Jason
    Wilson, Beverly
    Wei, Xingchang
    Rotaru, Carmen
    Bouffet, Eric
    Strother, Douglas
    NEURO-ONCOLOGY, 2008, 10 (03) : 393 - 393
  • [34] Primary Salivary Gland Malignancies Treated With Adjuvant Radiation Therapy With or Without Concurrent Chemotherapy: Prognostic Factors and Treatment Outcomes
    Gebhardt, B. J.
    Ohr, J.
    Bauman, J. E.
    Ferris, R. L.
    Duvvuri, U.
    Kim, S.
    Johnson, J. T.
    Heron, D. E.
    Clump, D. A., II
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 94 (04): : 955 - 956
  • [35] BMX-HGG: Phase II trial of newly diagnosed high-grade glioma treated with concurrent radiation therapy, temozolomide, and BMX-001.
    Peters, Katherine B.
    Cohen, Adam Louis
    Butowski, Nicholas A.
    Villano, John L.
    Giglio, Pierre
    McGranahan, Tresa
    Zhang, Chi
    Cloughesy, Timothy Francis
    Herndon, James Emmett
    Healy, Patrick
    MacLeod, David
    Penchev, Sara
    Silberstein, David
    Batinic-Haberle, Ines
    Spasojevic, Ivan
    Gad, Shayne
    Radoff, David
    Barboriak, Daniel
    Crapo, James
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [36] Prognostic impact of molecular phenotype in patients with recurrent anaplastic glioma treated with prolonged administration of temozolomide
    Kong, Doo-Sik
    Kim, Hong Rye
    Choi, Yoon-Ra
    Seol, Ho Jun
    Lee, Jung-Il
    Nam, Do-Hyun
    JOURNAL OF CLINICAL NEUROSCIENCE, 2015, 22 (09) : 1425 - 1429
  • [37] Impact of Concurrent Versus Adjuvant Chemotherapy on Inducing Lymphopenia in Glioma Patients Treated with Radiation Therapy
    Lin, A. J.
    Campian, J. L.
    Thotala, D.
    Rudra, S.
    Rao, Y. J.
    Hallahan, D. E.
    Huang, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E90 - E90
  • [38] Prolonged Administration of Temozolomide in Adult Patients with Anaplastic Glioma
    Freyschlag, C. F.
    Smolczyk, D. R.
    Janzen, E.
    Schmieder, K.
    Thome, C.
    Lohr, F.
    Wenz, F.
    Weiss, C.
    Tuettenberg, J.
    Seiz, M.
    ANTICANCER RESEARCH, 2011, 31 (11) : 3873 - 3877
  • [39] Author Correction: Anaplastic glioma: benefit of temozolomide clarified
    Diana Romero
    Nature Reviews Clinical Oncology, 2021, 18 (7) : 468 - 468
  • [40] Clinical and Dosimetric Predictors of Acute Severe Lymphopenia During Radiation Therapy and Concurrent Temozolomide for High-Grade Glioma
    Huang, Jiayi
    DeWees, Todd A.
    Badiyan, Shahed N.
    Speirs, Christina K.
    Mullen, Daniel F.
    Fergus, Sandra
    Tran, David D.
    Linette, Gerry
    Campian, Jian L.
    Chicoine, Michael R.
    Kim, Albert H.
    Dunn, Gavin
    Simpson, Joseph R.
    Robinson, Clifford G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 92 (05): : 1000 - 1007
12345